Cargando…
Current practice patterns and patient persistence with anticoagulant treatments for cancer‐associated thrombosis
BACKGROUND: Recommended therapeutic options for the management of venous thromboembolism (VTE) in patients with cancer are burdensome, and compliance with guidelines is unknown. OBJECTIVES: To describe current treatment patterns and to evaluate patient persistence on various anticoagulants. PATIENTS...
Autores principales: | Khorana, Alok A., McCrae, Keith R., Milentijevic, Dejan, Fortier, Jonathan, Nelson, Winnie W., Laliberté, François, Crivera, Concetta, Lefebvre, Patrick, Yannicelli, Daniel, Schein, Jeff |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058198/ https://www.ncbi.nlm.nih.gov/pubmed/30046670 http://dx.doi.org/10.1002/rth2.12002 |
Ejemplares similares
-
Effectiveness and safety of anticoagulants for the treatment of venous thromboembolism in patients with cancer
por: Streiff, Michael B., et al.
Publicado: (2018) -
Duration of anticoagulant therapy and VTE recurrence in patients with cancer
por: Khorana, Alok A., et al.
Publicado: (2019) -
The risk of recurrent VTE and major bleeding in a commercially‐insured population of cancer patients treated with anticoagulation
por: Khorana, Alok A., et al.
Publicado: (2018) -
Cancer associated thrombosis and mortality in patients with cancer stratified by khorana score risk levels
por: Khorana, Alok A., et al.
Publicado: (2020) -
Clinical outcomes of prolonged anticoagulation with rivaroxaban after unprovoked venous thromboembolism
por: Berger, Jeffrey S., et al.
Publicado: (2017)